Literature DB >> 10193367

Fibroproliferation and mast cells in the acute respiratory distress syndrome.

J M Liebler1, Z Qu, B Buckner, M R Powers, J T Rosenbaum.   

Abstract

BACKGROUND: Mast cells (MCs), which are a major source of cytokines and growth factors, have been implicated in various fibrotic disorders. To clarify the contribution of MCs to fibrogenesis, lung tissue from patients with the acute respiratory distress syndrome (ARDS) was examined during exudative through to fibroproliferative stages.
METHODS: Lung tissue was obtained from 17 patients with ARDS who had pathological features of the early exudative stage (n = 6) or the later reparative stages (n = 11), from four patients with idiopathic pulmonary fibrosis, and from three patients with normal lung tissue. Immunohistochemical localisation of tryptase (found in all human MCs), chymase (found in a subset of human MCs), alpha-smooth muscle actin (identifies myofibroblasts), and procollagen type I was performed.
RESULTS: Normal lung tissue exhibited myofibroblast and procollagen type I immunolocalisation scores each of < 5 and MC scores of 1. Increased scores were defined as myofibroblast and procollagen type I scores of > 10 and MC scores of > or = 2. Eighty percent of lung tissue samples from the early exudative stage of ARDS exhibited increased numbers of myofibroblasts, 50% had increased numbers of procollagen type I producing cells, while only 17% had increased numbers of MCs compared with control samples. All samples from the later reparative stages of ARDS had increased numbers of myofibroblasts and procollagen type I producing cells. Increased numbers of MCs were seen in 55% of samples from the reparative stages. There was no significant shift in MC phenotype in the ARDS samples.
CONCLUSIONS: Increased numbers of myofibroblasts and procollagen type I producing cells were frequently found early in the course of ARDS. MC hyperplasia was unusual during this stage, but was often a feature of the later reparative stages. MCs do not appear to initiate fibroproliferation in ARDS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193367      PMCID: PMC1745096          DOI: 10.1136/thx.53.10.823

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

Review 1.  The fibroproliferative phase of late adult respiratory distress syndrome.

Authors:  G U Meduri; M Eltorky; H T Winer-Muram
Journal:  Semin Respir Infect       Date:  1995-09

2.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

3.  Mast cells modulate acute ozone-induced inflammation of the murine lung.

Authors:  S R Kleeberger; J E Seiden; R C Levitt; L Y Zhang
Journal:  Am Rev Respir Dis       Date:  1993-11

4.  Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha.

Authors:  Y Kapanci; A Desmouliere; J C Pache; M Redard; G Gabbiani
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

5.  Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs.

Authors:  M Su; E Y Chi; M J Bishop; W R Henderson
Journal:  Am Rev Respir Dis       Date:  1993-02

6.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients.

Authors:  C Martin; L Papazian; M J Payan; P Saux; F Gouin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

7.  Heterogeneity of human mast cells based on cytokine content.

Authors:  P Bradding; Y Okayama; P H Howarth; M K Church; S T Holgate
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

8.  Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death.

Authors:  J G Clark; J A Milberg; K P Steinberg; L D Hudson
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

9.  Human cutaneous mast cells express basic fibroblast growth factor.

Authors:  J A Reed; A P Albino; N S McNutt
Journal:  Lab Invest       Date:  1995-02       Impact factor: 5.662

Review 10.  Serine proteinases of mast cell and leukocyte granules. A league of their own.

Authors:  G H Caughey
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

View more
  15 in total

Review 1.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome.

Authors:  Jeffrey C Horowitz; Zongbin Cui; Thomas A Moore; Tamara R Meier; Raju C Reddy; Galen B Toews; Theodore J Standiford; Victor J Thannickal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-10-07       Impact factor: 5.464

3.  Combined pirfenidone, azithromycin and prednisolone in post-H1N1 ARDS pulmonary fibrosis.

Authors:  Avinandan Saha; Preyas J Vaidya; Vinod B Chavhan; Amolkumar Achlerkar; Jörg D Leuppi; Prashant N Chhajed
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 4.  Uncovering the Mast Cell Response to Mycobacterium tuberculosis.

Authors:  Ivonne Torres-Atencio; Ariadne Campble; Amador Goodridge; Margarita Martin
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 5.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

6.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

7.  Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissue.

Authors:  Maina M B Morales; Ruy C Pires-Neto; Nicole Inforsato; Tatiana Lanças; Luiz F F da Silva; Paulo H N Saldiva; Thais Mauad; Carlos R R Carvalho; Marcelo B P Amato; Marisa Dolhnikoff
Journal:  Crit Care       Date:  2011-01-06       Impact factor: 9.097

8.  Marked stem cell factor expression in the airways of lung transplant recipients.

Authors:  Carla A Da Silva; Mélanie Adda; Marc Stern; Frédéric de Blay; Nelly Frossard; Dominique Israel-Biet
Journal:  Respir Res       Date:  2006-06-16

9.  Sepsis-induced lung inflammation is modulated by insulin.

Authors:  Luciano Ribeiro Filgueiras; Vera L Capelozzi; Joilson O Martins; Sonia Jancar
Journal:  BMC Pulm Med       Date:  2014-11-15       Impact factor: 3.317

10.  Tryptase is involved in the development of early ventilator-induced pulmonary fibrosis in sepsis-induced lung injury.

Authors:  Jesús Villar; Nuria E Cabrera-Benítez; Francisco Valladares; Sonia García-Hernández; Ángela Ramos-Nuez; José Luís Martín-Barrasa; Mercedes Muros; Robert M Kacmarek; Arthur S Slutsky
Journal:  Crit Care       Date:  2015-04-03       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.